Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipertance for Carotid IMT in Hypertension and Hypercholesterolemia
NCT04306627Phase 4Unknown
- Sponsor
- Yerevan State Medical University
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in essential hypertension, hypercholesterolemia and atherosclerosis (2 arms), sponsored by Yerevan State Medical University. Primary endpoint: Change in mean Intima Media Thickness of the Common Carotid Artery at 6 months. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
essential hypertensionhypercholesterolemiaatherosclerosis
Beyond the preview
Go deeper on NCT04306627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04306627.